Quick Details
- ProName: Gatifloxacin
- CasNo: 112811-59-3
- Molecular Formula: C19H22FN3O4
- Appearance: White or light yellow crystalline powd...
- PackAge: 25KG/Drum
- Purity: ≥99%
- Storage: 5000KG
- Transportation: By sea
- LimitNum: 1 Kilogram
Superiority
Name:Gatifloxacin
Synonyms:1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid
Molecular Formula:…
Details
Name:Gatifloxacin
Synonyms:1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid
Molecular Formula: C19H22FN3O4
Molecular Weight:375.40
Appearance: White or light yellow crystalline powder
Assay:≥98.5%
CAS:112811-59-3
Characteristics: Almost white crytallline
Impurity: ≤1.0%
Water contains : 4%-8%
Assay: ≥98.5%
Appearance: White or light yellow crystalline powder
Specifications:
ITEM SPECIFICATION RESULT
Description White or light yellow crystalline powder Conform
Water % 4.0-8.0 6.2
Related Substance % ≤1.0 0.45
Residue of Ignition % ≤0.2 0.13
Heavy Metals % ≤0.002 Conforms
Assay % ≥98.50 99.32
Fluorine % ≥4.6 4.8
Clarity (650nm) T ≥95.0 98.8
Color Index (420nm) A ≤0.25 0.15
3. Useage:
This product is mainly used by a variety of infections caused by sensitive pathogens of diseases, including acute exacerbation of chronic bronchitis, acute sinusitis, community acquired pneumonia, simple urinary tract infection (cystitis) and complicated urinary tract infection, acute pyelonephritis, the male urinary tract inflammation or rectal gonococcal infection and gonococcal cervical infection in women
Packaging:25kg/drum1.Gatifloxacin
2.CAS No112811-59-3
3.MFC19H22FN3O4
4.Appearance White or light yellow crystalline powder
1.CAS112811-59-32.Characteristics Almost white crytallline3.Impurity ≤1.0%4.Water contains 4%-8%5Assay ≥99%
1.Synonyms1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acidMolecular FormulaC19H22FN3O4Molecular Weight375.40Appearance White or light yellow crystalline powderCAS112811-59-32.SpecificationsITEMSPECIFICATIONRESULTDescriptionWhite or light yellow crystalline powderConformWater %4.0-8.06.2Related Substance %≤1.00.45Residue of Ignition %≤0.20.13Heavy Metals %≤0.002ConformsAssay %≥98.5099.32Fluorine %≥4.64.8Clarity (650nm) T≥95.098.8Color Index (420nm) A≤0.250.151.G1.Gatifloxacin2.CAS No112811-59-3 3.MFC19H22FN3O4 4.Appearance White or light yellow crystalline powder
1.CAS112811-59-32.Characteristics Almost white crytallline3.Impurity ≤1.0%4.Water contains 4%-8%5Assay ≥98.5%
1.Synonyms1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acidMolecular FormulaC19H22FN3O4Molecular Weight375.40Appearance White or light yellow crystalline powderCAS112811-59-32.SpecificationsITEMSPECIFICATIONRESULTDescriptionWhite or light yellow crystalline powderConformWater %4.0-8.06.2Related Substance %≤1.00.45Residue of Ignition %≤0.20.13Heavy Metals %≤0.002ConformsAssay %≥98.5099.32Fluorine %≥4.64.8Clarity (650nm) T≥95.098.8Color Index (420nm) A≤0.250.153.UsageThis product is mainly used by a variety of infections caused by sensitive pathogens of diseases, including acute exacerbation of chronic bronchitis, acute sinusitis, community acquired pneumonia, simple urinary tract infection (cystitis) and complicated urinary tract infection, acute pyelonephritis, the male urinary tract inflammation or rectal gonococcal infection and gonococcal cervical infection in women 4.Packaging25kg/drum